COCRYSTAL PHARMA NEW O.N. Net Asset Momentum
COCRYSTAL PHARMA NEW O.N. net asset momentum. COCRYSTAL PHARMA NEW O.N. (8CC) recorded a net asset momentum of -33.5% as of December 2025, with net assets of €6.33 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Explore COCRYSTAL PHARMA NEW O.N. (8CC) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
YoY Momentum
Current Net Assets
Years of Data
Country
Net Asset Momentum of COCRYSTAL PHARMA NEW O.N. (2021–2025)
Net asset momentum of COCRYSTAL PHARMA NEW O.N. from 2021 to 2025. This chart tracks COCRYSTAL PHARMA NEW O.N.'s year-over-year net asset growth across 5 annual reporting periods from 2021 to 2025. The most recent momentum reading is -33.5%, with net assets of €6.33 Million EUR as of December 2025. See COCRYSTAL PHARMA NEW O.N. net assets for net asset value and shareholders' equity analysis.
COCRYSTAL PHARMA NEW O.N. Net Asset Momentum by Year (2021–2025)
COCRYSTAL PHARMA NEW O.N. net asset momentum by year from 2021 to 2025. The table below shows the complete annual net asset history for COCRYSTAL PHARMA NEW O.N. from 2021 to 2025, covering 5 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and overall valuation, see 8CC market cap overview.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €6.33 Million | €9.71 Million | €3.38 Million | ▼ -33.5% |
| 2024 | €9.52 Million | €13.46 Million | €3.93 Million | ▼ -63.9% |
| 2023 | €26.38 Million | €31.26 Million | €4.88 Million | ▼ -33.3% |
| 2022 | €39.57 Million | €40.84 Million | €1.27 Million | ▼ -49.0% |
| 2021 | €77.55 Million | €79.39 Million | €1.84 Million | — |